USFDA Nod for Zydus Cadila for the treatment of schizophrenia
Drug company Zydus Cadila announced on Thursday that Brexpiprazole tablets, used for the treatment of Schizophrenia, have received market approval from the US health regulator in the American market. Tentual marketing approval for Brexpiprazol tablets of 0....
11 September, 2021
Read more